MFDS — authorised 14 December 1990
- Marketing authorisation holder: FOUGERA PHARMS
- Status: likely_approved
🇰🇷 Cutivate in South Korea
MFDS authorised Cutivate on 14 December 1990
Marketing authorisation
Cutivate in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in South Korea
Frequently asked questions
Is Cutivate approved in South Korea?
Yes. MFDS authorised it on 14 December 1990.
Who is the marketing authorisation holder for Cutivate in South Korea?
FOUGERA PHARMS holds the South Korean marketing authorisation.